The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
@Jimmy - before judging JB understand that he was a shareholder like us but far bigger and also the main founder of AMGO, he was cornered, unable to vote and ignored by the board while watching his value dry up. I would think that would have driven anyone let alone a major stakeholder founder to be volatile.
Well there goes the current BoD’s one and only ace to play! With skin in the game I don’t think its the last we will hear of GC. May well be the magic JB.GC partnership many of us hoped for....
Anyone else here with Fidelity? I am not seeing corporate actions to vote on...
Coronavirus: Testing issues 'will be solved in a matter of weeks', says Han**** https://www.bbc.co.uk/news/uk-54163683
JB is a shareholder like many of us, but with a much bigger stake, he was angry with the old BoD for theIr disastrous management. Frankly am surprised how few older holders are vocally onside with him, and I think GC is one quiet contender, others who got in on the lows well done.
Agree expru - AMGO need to step up and challenge selective claims where they did in fact make proper checks, or those sent in fraudulently given CMCs have no risk to do so on behalf of applicants, although where they had failed to make the proper checks and more specifically around top ups, pay up. I’d guess if that was successful around 65% of the £ put aside would Go right back to the bottom line.
That latest RNS was to cast doubt and IMHO a poor card to play in this, and if that’s all they have it puts them further into question. Based on what I’ve seen researched, they were not only asleep at the wheel, they drove the car into the wall. I still think the best recovery here is a partnership between JB/GC, the biggest risk remains around claims.
Anyone else here think members of the current BoD may be in cahoots or a sort with the FCA???
I don’t get it, RNS for CE mark I grant is not a reflect of sales/profit but it is one step closer - yet the SP goes down!
I have never before intentionally bought a share for short teem, I am not a day trader. When I picked up AMGO around 5 weeks ago, I knew most of the risks and learned some since. I bought not thinking about what the SP will look like this year, but post Covid in 2021. I though was simply, AMGO will either die, or end up with a Market Cap of about £200-350M. I still think this am added as believe even more that latter will happen. That said any jump up sooner would be most welcome!!!!
Nice rns - given conditions
Hi Rutends - the upside looks pretty good to me but as you say the risk is around claims / FCA, in truth the FCA are focused on Guarantor loans, which for NSF are about 20% of their offerings. So they should weather it given the future will likely bump up the need for loans.
Let’s be honest, it’ll be a long time if ever Amigo is to grow back to a £1 billion + market cap, but the level now is ridiculously low even with all known issues.